(Q40328353)
Statements
1 reference
The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib (English)
1 reference
1 reference
1 reference
Adele Carotenuto
1 reference
Monica R Maiello
1 reference
Manuela Campiglio
1 reference
Mario Mancino
1 reference
Sylvie Menard
1 reference
Maria Napolitano
1 reference
Giuseppe Viglietto
1 reference
1 May 2006
1 reference
1 reference
207
1 reference
2
1 reference
420-427
1 reference
Identifiers
1 reference
1 reference